Constance A. Wilkinson
HRSA Establishes January 1, 2019 Effective Date for 340B Ceiling Price and Civil Monetary Penalty Rule
Health Care and Life Sciences ·
CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model
Health Care and Life Sciences ·
CMS Finalizes Policy and Technical Changes to the Medicare Advantage and Part D Programs for CY 2019
Administrative and Regulatory ·
White House 2019 Budget and White Paper Shape Ambitious Policy to Reduce Drug Prices
Government and Public Policy ·
CMS Final Rule Will Reduce Medicare Part B Drug Payments by Nearly 30% for 340B Hospitals
Health Care and Life Sciences ·